Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Quiz

RSV Vaccine Development Challenges

Nine respiratory syncytial virus (RSV) prevention candidates are in phase 3 trials, including several vaccines for older adults. Researchers recently reviewed the development pipeline. 

Advertisement

Advertisement